These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18283785)

  • 1. The 5q- syndrome.
    Giagounidis AA; Aul C
    Cancer Treat Res; 2008; 142():133-48. PubMed ID: 18283785
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
    Cazzola M
    Haematologica; 2008 Jul; 93(7):967-72. PubMed ID: 18591621
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes.
    Melchert M; Kale V; List A
    Curr Opin Hematol; 2007 Mar; 14(2):123-9. PubMed ID: 17255789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome abnormalities in myelodysplastic syndromes.
    Nowell PC
    Semin Oncol; 1992 Feb; 19(1):25-33. PubMed ID: 1736367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myelodysplastic syndrome associated with 5q deletion, review of 3 cases].
    Khanfir A; Frikha M; Mseddi S; Elloumi M; Daoud J; Makni F; Amouri A; Gargouri J; Saad A; Souissi T
    Tunis Med; 1997 Mar; 75(3):127-31. PubMed ID: 9506035
    [No Abstract]   [Full Text] [Related]  

  • 6. An uncommon case of a child with del(5q) and hypocellular myelodysplastic syndrome.
    de Souza DC; Otero L; Tavares Rde C; Dobbin J; Abdelhay E; Fernandez Tde S
    Pediatr Blood Cancer; 2010 Oct; 55(4):767. PubMed ID: 20589660
    [No Abstract]   [Full Text] [Related]  

  • 7. Revealing the pathogenesis of the 5q- syndrome.
    Valent P
    Eur J Clin Invest; 2008 Aug; 38(8):539-40. PubMed ID: 18717823
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulatory drugs in the treatment of myelodysplastic syndromes.
    Ortega J; List A
    Curr Opin Oncol; 2007 Nov; 19(6):656-9. PubMed ID: 17906467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ribosomal protein in impaired erythropoiesis: Diamond-Blackfan anemia and 5q- syndrome].
    Ito E
    Rinsho Ketsueki; 2009 Oct; 50(10):1539-47. PubMed ID: 19915364
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
    Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
    Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 5q- syndrome].
    Adès L; Fenaux P
    Rev Prat; 2010 Dec; 60(10):1420-2. PubMed ID: 21425544
    [No Abstract]   [Full Text] [Related]  

  • 13. A delayed yet durable response to very short lenalidomide therapy and unexpected clone redistribution in a case of myelodysplastic syndrome with del(5q) and del(20q).
    Xu F; Li X; Chang C; He Q; Zhang Z; Zhang Q; Wu L
    Leuk Res; 2009 Nov; 33(11):e199-202. PubMed ID: 19592091
    [No Abstract]   [Full Text] [Related]  

  • 14. 5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders?
    Koike T; Uesugi Y; Toba K; Narita M; Fuse I; Takahashi M; Shibata A
    Leukemia; 1995 Mar; 9(3):517-8. PubMed ID: 7885050
    [No Abstract]   [Full Text] [Related]  

  • 15. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
    Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of the glutathione-S-transferase T1-null genotype in patients with primary myelodysplastic syndrome and 5q deletion.
    Stavropoulou C; Sambani C; Rigana H; Georgakakos VN; Voutsinas G; Manola KN; Pantelias GE; Makropoulos V;
    Leukemia; 2008 Aug; 22(8):1643-6. PubMed ID: 18305556
    [No Abstract]   [Full Text] [Related]  

  • 17. Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomide.
    Eclache V; Da Rocha A; Le Roux G; Fenaux P
    Haematologica; 2008 Feb; 93(2):315-6. PubMed ID: 18245660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lenalidomide in the management of myelodysplasia with del 5q.
    Kelaidi C; Eclache V; Fenaux P
    Br J Haematol; 2008 Feb; 140(3):267-78. PubMed ID: 18217896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome.
    Nano R; Invernizzi R; Pecci A; Civallero M; Gerzeli G
    Haematologica; 2000 Jul; 85(7):765-6. PubMed ID: 10897132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Apropos of the case "Erythroblastopenia associated with myelodysplastic syndrome"].
    Aventín A
    Sangre (Barc); 1996 Dec; 41(6):483. PubMed ID: 9148428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.